Long-noncoding RNAs in basal cell carcinoma
- 331 Downloads
Long noncoding RNAs (lncRNAs) are fundamental regulators of pre- and post-transcriptional gene regulation. Over 35,000 different lncRNAs have been described with some of them being involved in cancer formation. The present study was initiated to describe differentially expressed lncRNAs in basal cell carcinoma (BCC). Patients with BCC (n = 6) were included in this study. Punch biopsies were harvested from the tumor center and nonlesional epidermal skin (NLES, control, n = 6). Microarray-based lncRNA and mRNA expression profiles were identified through screening for 30,586 lncRNAs and 26,109 protein-coding transcripts (mRNAs). The microarray data were validated by RT-PCR in a second set of BCC versus control samples. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of mRNAs were performed to assess biologically relevant pathways. A total of 1851 lncRNAs were identified as being significantly up-regulated, whereas 2165 lncRNAs were identified as being significantly down-regulated compared to nonlesional skin (p < 0.05). Oncogenic and/or epidermis-specific lncRNAs, such as CASC15 or ANRIL, were among the differentially expressed sequences. GO analysis showed that the highest enriched GO targeted by up-regulated transcripts was “extracellular matrix.” KEGG pathway analysis showed the highest enrichment scores in “Focal adhesion.” BCC showed a significantly altered lncRNA and mRNA expression profile. Dysregulation of previously described lncRNAs may play a role in the molecular pathogenesis of BCC and should be subject of further analysis.
KeywordsLong noncoding RNAs Basal cell carcinoma Noncoding RNAs Epithelial skin cancer Nonmelanoma skin cancer
Compliance with ethical standards
Conflicts of interest
All authors hereby disclose any commercial associations that may pose or create a conflict of interest with the information presented in this manuscript. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper. Daniel Sand was supported by the Heed Ophthalmic Foundation.
This study conformed to local requirements following ethical and investigational committee review, informed consent, and other statutes or regulations regarding the protection of the rights and welfare of human subjects participating in medical research (Ethical Review Board of Ruhr-University Bochum, Germany).
- 6.Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, et al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. 2012;51:916–22.CrossRefPubMedGoogle Scholar
- 9.Guo X, Gao L, Wang Y, Chiu DK, Wang T, Deng Y et al. Advances in long noncoding rnas: Identification, structure prediction and function annotation. Brief Funct Genomics 2015, in pressGoogle Scholar
- 34.Sokal RR, Michener CD. A statistical method for evaluating systematic relationships. Univ Kansas Sci Bull. 1958;28:1409–38.Google Scholar
- 47.Lessard L, Liu M, Marzese DM, Wang H, Chong K, Kawas N et al. The casc15 long intergenic noncoding rna locus is involved in melanoma progression and phenotype switching. J Invest Dermatol 2015;135(10):2464–74.Google Scholar
- 50.Iranpour M, Soudyab M, Geranpayeh L, Mirfakhraie R, Azargashb E, Movafagh A et al. Expression analysis of four long noncoding rnas in breast cancer. Tumour Biol 2015, in pressGoogle Scholar
- 52.Wan DC, Wang KC. Long noncoding RNA: significance and potential in skin biology. Cold Spring Harb Perspect Med. 2014;4.Google Scholar